相关实验视频

Updated: Jun 23, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

低剂量丹塞:一种候选的前性精密药物,用于治疗酒精使用障碍的内分类型

Bankole Johnson¹, Hannu Alho², Giovanni Addolorato³

¹Adial Pharmaceuticals Inc., Division of Biomedical Sciences, Larkin University, Miami, USA.

European journal of internal medicine

|June 14, 2024

概括

在患有酒精使用障碍 (AUD) 和特定遗传特征的人群中,Ondansetron (AD04) 显著减少了大量饮酒的日子. 这种精准医学方法为AUD提供了一个有前途的,耐受良好的治疗选择,而不需要戒断.

科学领域:

药物基因组学药物基因组学
精准医学是一门精准的医学.
神经科学是一个神经科学.

背景情况:

酒精使用障碍 (AUD) 是一种具有显著遗传性的全球健康危机,表明存在遗传因素.
精准医学方法,如使用丹塞 (AD04),针对基于遗传和临床因素的特定患者亚组.
AD04是一种5-HT3抗剂,在AUD的生物心理社会背景下调节生物遗传信号.

研究的目的:

评估低剂量AD04在治疗中度至重度AUD患者的疗效和安全性.
根据饮酒严重程度和与血清素相关的遗传变异,评估AD04在预分层AUD人群中的有效性.
探索AD04作为一种精确的药物干预措施,以减少饮酒.

主要方法:

一个为期6个月的随机,安慰剂控制的III期临床试验,涉及303名参与者,患有中度至严重的AUD.
参与者通过大量/非常大量的饮酒和特定的血清素载体和5-HT3AB受体的遗传变异进行了预分层.
低剂量AD04 (每天两次0.33毫克) 或安慰剂被管理,加上简短的行为合规增强治疗 (BBCET).

主要成果:

在第6个月,AD04治疗导致严重饮酒日 (PHDD) 的月度百分比显著降低 (-46.7% vs -38.1%).
接受AD04的患者被诊断为AUD的可能性较小,生活质量改善 (WHOQOL-BREF).
具有特定基因型的重度饮酒个体对AD04的反应最强,这表明了特殊的安全性.

结论:

AD04对于AUD和特定遗传特征的人来说是一个有前途的治疗方法,可以减少大量饮酒而不需要戒酒.
这种精准医学方法代表了AUD管理的重大进步,通过准降低危害.
与安慰剂相似的AD04的安全性概况提高了其在AUD治疗中的潜在可访问性和接受性.

关键词:

5HT3 3HT3 5HT3 3HT3 5HT3 5HT3 5HT3 5HT3 5HT3 5HT3 5HT3 5HT3 AD04 AD04 AD04 AD04 AD04 AD04 的意思是说在 AUD 中,AUD 是 AUD.酒精饮料酒精饮料酒精饮料酒精饮料这就是BBCET.生物遗传生物遗传学末型是一种内类型.在 Ondansetron 中.精准医学是一门精准的医学.

更多相关视频

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila

Published on: April 15, 2015

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

CNS Depressants: Alcohol and Nicotine

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...